Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
AUPH.OQ - Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc. - Special Call
Mar 26, 2020 / 09:15PM GMT
=====================
Conference Call Participants
=====================
* Joseph Vassalotti;Nephrologist
* Keisha Gibson;University of North Carolina
=====================
Presentation
--------------------------------------------------------------------------------
Keisha Gibson;University of North Carolina, [1]
--------------------------------------------------------------------------------
(technical difficulty)
And thank you to the National Kidney Foundation and all of the sponsors of this meeting that worked so hard to make sure that we could join you virtually today.
I have the honor of representing the AURORA study group to present the results of our Phase III randomized trial, which assessed the superiority of voclosporin in combination with standard of care therapy over standard of care therapy alone in patients with active lupus nephritis.
These are my disclosures.